Table 2 Comparison of risk factors in Stanford type A patients with or without complications.

From: Comparative study on clinical efficacy of different methods for the treatment of intramural aortic hematoma

Risk factor

Complications or death (19)

No complications (29)

total (n = 48)

P

Male

8 (42.11)

13 (44.83)

21 (43.75)

0.85

Female

11 (57.89)

16 (55.17)

27 (56.25)

0.91

Age

66.5 ± 3.5

64.5 ± 5.5

65.6 ± 9.2

0.55

Hypertension

14 (73.68)

96 (84.21)

39 (81.3)

0.20

Delayed diagnosis (h)

8.7 ± 2.5

9.4 ± 3.0

9.3 ± 2.7

0.4

History of smoking

6 (31.58)

3 (10.34)

9 (18.75)

0.012

Diabetes

1 (0.048)

1 (0.030)

2 (0.037)

Heart disease

1 (5.26)

2 (6.70)

3 (6.25)

Focal intimal rupture

5 (26.32)

3 (10.34)

8 (16.67)

0.020

Thoracic or pericardial effusion

20 (95.24)

23 (69.70)

43 (89.6)

0.035

Haematoma thickness ≥ 11 mm

8 (42.11)

1 (3.45)

9 (18.75)

0.001

Maximum aortic diameter ≥ 50 mm

10 (52.63)

2 (6.90)

12 (25.00)

0.001